Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 3, 2026Reported sale · Form 4Virginia Ruth Sanzone, VP, General Counsel · $369.2KOpen the filing ↗
- Sep 3, 2026Reported sale · Form 4Virginia Ruth Sanzone, VP, General Counsel · $208.5KOpen the filing ↗
- Sep 3, 2026Reported sale · Form 4Virginia Ruth Sanzone, VP, General Counsel · $122.7KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record1,99711 flagged findings
Reported transactions (Form 4)80since May 28, 2025 · and 4 other holdings
Corporate events (8-K)30since Feb 9, 2017
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems.
Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-07capital return (buybacks/dividends)recentOpen filing ↗“…obligations paid on their behalf. During the three months ended March 31, 2025, our employees surrendered 58,858 shares of…”
+1 more passage from the same document
- “…Approximate dollar value of shares that may yet be purchased under the program (1) 01/01/2026 — 01/31/2026 — $ — — $ 100,000,000…”
- 2026-02-19capital return (buybacks/dividends)recentOpen filing ↗“…program Approximate dollar value that may yet be purchased under the program (1) 10/01/2025 - 10/31/2025 — $ — — $ 100,000,000…”
+1 more passage from the same document
- “…$12.0 million in minimum statutory withholding obligations paid on their behalf. In 2023, our employees surrendered 59,377 shares…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 1,997)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 3, 26Form 144 ↗Notice of proposed sale
- Sep 3, 26Form 4 ↗Insider transaction
- Sep 1, 26Form 144 ↗Notice of proposed sale
- Sep 1, 26Form 4 ↗Insider transaction
- Aug 31, 26Form 144 ↗Notice of proposed sale
- Aug 31, 26Form 4 ↗Insider transaction
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Fuller & Thaler Asset Management, Inc. · 5.2% · event on Jun 30, 26 · amendment
- Aug 13, 26Form 144 ↗Notice of proposed sale
- Aug 13, 26Form 4 ↗Insider transaction
- Aug 13, 26SCHEDULE 13G/A ↗Passive stake · JANUS HENDERSON GROUP Ltd. · 11.1% · event on Jun 30, 26 · amendment
- Aug 12, 26Form 4 ↗Insider transaction
Notice of proposed sale · 3 Form 144 filingsshow all 3hide
- Aug 12, 26Form 144 ↗Notice of proposed sale
- Aug 11, 26Form 144 ↗Notice of proposed sale
- Aug 11, 26Form 144 ↗Notice of proposed sale
- Aug 6, 2610-Q ↗Quarterly report
- Aug 6, 268-K ↗Current report · Results
- May 22, 26Form 144 ↗Notice of proposed sale
- May 22, 26Form 4 ↗Insider transaction
- May 18, 268-K ↗Current report · Bylaws or fiscal year change · Shareholder vote results
- May 15, 26Form 4 ↗Insider transaction
- May 14, 26Form 144 ↗Notice of proposed sale
- May 13, 26SCHEDULE 13G/A ↗Passive stake · Fuller & Thaler Asset Management, Inc. · 4.9% · event on Mar 31, 26 · amendment
- May 13, 26Form 4 ↗Insider transaction
1,997 filings on record, the oldest from Sep 8, 95.
Listing the 25 most recent filings of the 1,997 on record.
13154
9 senior executive changes2022 – 2026show all 9hide
- Feb 20, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- May 14, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Oct 2, 24A senior executive left or was appointed8-K 5.02 ↗
- Feb 29, 24A senior executive left or was appointed8-K 5.02 ↗
- May 22, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jan 3, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 20, 22A senior executive left or was appointed8-K 5.02 ↗
- Feb 18, 22A senior executive left or was appointed8-K 5.02 ↗
- Feb 1, 22A senior executive left or was appointed8-K 5.02 ↗
- Jan 7, 22Sold unregistered shares+5 more in the same filing8-K 3.02 ↗
- Jan 4, 22A senior executive left or was appointed8-K 5.02 ↗
- Sep 8, 21Entered a material agreement+3 more in the same filing8-K 1.01 ↗
11 senior executive changes2017 – 2021show all 11hide
- Jul 7, 21A senior executive left or was appointed8-K 5.02 ↗
- Feb 28, 20A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jan 6, 20A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jul 8, 19A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 5, 19A senior executive left or was appointed8-K 5.02 ↗
- Mar 4, 19A senior executive left or was appointed8-K 5.02 ↗
- May 17, 18A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jan 5, 18A senior executive left or was appointed8-K 5.02 ↗
- Jun 9, 17A senior executive left or was appointed8-K 5.02 ↗
- May 12, 17A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- May 8, 17A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Feb 9, 17Entered a material agreement+5 more in the same filing8-K 1.01 ↗
The record reaches back to Jan 3, 05.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Nov 18, 15Restructuring plan with committed costs8-K 2.05 ↗
The full record holds 1 stress filing.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- JANUS HENDERSON GROUP Ltd.11.1%Jun 30, 26SCHEDULE 13G/A ↗3 earlier filings
- Vanguard Portfolio Management5.8%Mar 31, 26SCHEDULE 13G ↗
- Fuller & Thaler Asset Management, Inc.5.2%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
- Vanguard Capital Management5.2%Mar 31, 26SCHEDULE 13G ↗
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Sep 3, VIRGINIA SANZONE filed notice of intent to sell up to $819K. That is about 0.02% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $819K across 4 trades on Sep 3, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+6 more recent notices · 6 with a later sale
- Sep 3, 26Sell$369KVirginia Ruth SanzoneVP, General Counsel↗
- Sep 3, 26Sell$209KVirginia Ruth SanzoneVP, General Counsel↗
- Sep 3, 26Sell$123KVirginia Ruth SanzoneVP, General Counsel↗
- Sep 3, 26Sell$119KVirginia Ruth SanzoneVP, General Counsel↗
- Sep 1, 26Sell$1.1MBrian Michael BonnellChief Financial Officer↗
- Aug 31, 26Sell$293KBrian Michael BonnellChief Financial Officer↗
- Aug 31, 26Sell$329KBrian Michael BonnellChief Financial Officer↗
- Aug 31, 26Sell$792KBrian Michael BonnellChief Financial Officer↗
- Aug 31, 26Sell$194KBrian Michael BonnellChief Financial Officer↗
- Aug 13, 26Sell$982KDaniel WoolsonVP, GM-Infusion Capital↗
- Aug 12, 26Sell$401KBen SousaChief Information Officer↗
- Aug 11, 26Sell$69KELISHA W FINNEY↗
There are 4 more transactions in this stretch.
Stock compensation, tax and giftsshow the 24 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- May 13, 26Compensationamount n/aELISHA W FINNEY↗
- May 13, 26Compensationamount n/aDavid F Hoffmeister↗
- May 13, 26Compensationamount n/aKOLLEEN T KENNEDY↗
- May 13, 26Compensationamount n/aDonald Abbey↗
- May 13, 26Compensationamount n/aDavid C. Greenberg↗
- May 13, 26Compensationamount n/aLaurie Hernandez↗
- May 12, 26Compensation$245KDavid C. Greenberg↗
- Mar 25, 26Otheramount n/aDonald Abbey↗
- Mar 15, 26Compensationamount n/aVivek JainChairman and CEO↗
- Mar 15, 26Tax$1.2MVivek JainChairman and CEO↗
- Mar 15, 26Compensationamount n/aVivek JainChairman and CEO↗
- Mar 15, 26Tax$339KVivek JainChairman and CEO↗
- Mar 15, 26Compensationamount n/aVirginia Ruth SanzoneVP, General Counsel↗
- Mar 15, 26Tax$396KVirginia Ruth SanzoneVP, General Counsel↗
- Mar 15, 26Compensationamount n/aVirginia Ruth SanzoneVP, General Counsel↗
- Mar 15, 26Tax$113KVirginia Ruth SanzoneVP, General Counsel↗
- Mar 15, 26Compensationamount n/aDaniel WoolsonVP, GM-Infusion Capital↗
- Mar 15, 26Tax$163KDaniel WoolsonVP, GM-Infusion Capital↗
- Mar 15, 26Compensationamount n/aChristian B. VoigtlanderChief Operating Officer↗
- Mar 15, 26Tax$793KChristian B. VoigtlanderChief Operating Officer↗
- Mar 15, 26Compensationamount n/aChristian B. VoigtlanderChief Operating Officer↗
- Mar 15, 26Tax$226KChristian B. VoigtlanderChief Operating Officer↗
- Mar 15, 26Compensationamount n/aBrian Michael BonnellChief Financial Officer↗
- Mar 15, 26Tax$730KBrian Michael BonnellChief Financial Officer↗
The full record holds 332 transactions and goes back to Feb 2, 23.
Its sector and its market
Icu Medical Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Icu Medical Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Icu Medical Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 1,997 documents on file, from Sep 8, 1995 to Sep 3, 2026.
- Company description
- Wikipedia, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.